1
191
5
3
1
| Cat. No. | Product Name | ||
|---|---|---|---|
| L8100 | 细胞周期化合物库 | 695 compounds | |
|
xnu |
|||
| L8720 | 细胞焦亡化合物库 | 1077 compounds | |
|
xnu |
|||
| L7300 | 钾通道分子库 | 160 compounds | |
|
xnu |
|||
| L7600 | 趋化因子抑制剂库 | 59 compounds | |
|
xnu |
|||
| L9500 | 表型筛选靶点鉴定库 | 1832 compounds | |
|
xnu |
|||
| DO1200 | 药物靶点库 | 54000 compounds | |
| 数量多，含53200种小分子化合物，是高通量筛选的有力工具； | |||
| L3700 | JAK-STAT 化合物库 | 256 compounds | |
|
xnu |
|||
| L5900 | 血脑屏障通透化合物库 | 516 compounds | |
|
xnu |
|||
| L1100 | 蛋白酶抑制剂库 | 344 compounds | |
|
xnu |
|||
| L3300 | 组胺&褪黑色素化合物库 | 155 compounds | |
|
xnu |
|||
| L2610 | 神经递质受体化合物库 | 1513 compounds | |
|
xnu |
|||
| VM1400 | 多样性核心库Part2 | 25920 compounds | |
|
分子量<500，主要集中于250- |
|||
| L2550 | 谷氨酰胺代谢化合物库 | 580 compounds | |
|
xnu |
|||
| L1120 | AMPK靶向分子库 | 64 compounds | |
|
xnu |
|||
| L7110 | 抗高血压化合物库 | 719 compounds | |
|
xnu |
|||
| L7500 | 凝血与抗凝化合物库 | 154 compounds | |
|
xnu |
|||
| DC1140 | 特权片段注释化合物库-Ligand-gated | 9028 compounds | |
| L2400 | 内分泌激素分子库 | 813 compounds | |
|
xnu |
|||
| L2000 | 抑制剂库 | 7618 compounds | |
|
xnu |
|||
| NY1000 | 天然产物衍生物库 | 4000 compounds | |
|
22个天然产物骨架， |
|||
| L9420 | 外泌体相关化合物库 | 54 compounds | |
|
xnu |
|||
| L1710 | 抗COVID-19化合物库 | 1160 compounds | |
|
xnu |
|||
| L9230 | ReFRAME 化合物库 | 3274 compounds | |
|
xnu |
|||
| DC1180 | 特权片段注释化合物库-Lyases | 19530 compounds | |
| L4900 | 心血管毒性化合物库 | 127 compounds | |
|
xnu |
|||
| DP9200 | DGK抑制剂库 | 12000 compounds | |
|
包含12000种类药化合物，源自知名品牌Che |
|||
| L5300 | 线粒体靶向库 | 447 compounds | |
|
xnu |
|||
| L9210 | 儿童药物库 | 1015 compounds | |
|
xnu |
|||
| L6010 | 天然产物库 | 3720 compounds | |
|
xnu |
|||
| L6020 | 天然产物单体化合物库 | 19377 compounds | |
|
xnu |
|||
| LF1000 | 预制多样性库 | 50000 compounds | |
|
For your convenience, there are Diversity Sets of 5,000, 10,000, 15,000, and 20,000 co |
|||
| L1380 | 转录因子库 | 704 compounds | |
|
xnu |
|||
| DC1150 | 特权片段注释化合物库-GPCR Family B | 9320 compounds | |
| DC1170 | 特权片段注释化合物库-Oxidoreductases | 8812 compounds | |
| L9411 | 半胱氨酸共价化合物库 | 72 compounds | |
|
半胱氨酸共价库包含xnu |
|||
| L4660 | 神经疾病库Plus | 1246 compounds | |
|
xnu |
|||
| L3500 | 组蛋白修饰化合物库 | 362 compounds | |
|
xnu |
|||
| L2192 | 抗胰腺癌化合物库 | 2267 compounds | |
|
xnu |
|||
| L6700 | 抗癌天然产物库 | 1471 compounds | |
|
xnu |
|||
| DC1190 | 特权片段注释化合物库-Sigma Opioid receptors | 8724 compounds | |
| L3900 | DNA 损伤和修复分子库 | 937 compounds | |
|
xnu |
|||
| L2160 | 抗癌活性化合物库 | 2439 compounds | |
|
xnu |
|||
| L9610 | 环肽库 | 58 compounds | |
|
xnu |
|||
| L5700 | 精选片段库 | 246 compounds | |
|
xnu |
|||
| L2110 | 抗癌上市药物库 | 1806 compounds | |
|
xnu |
|||
| L3200 | 自噬库 | 1248 compounds | |
|
xnu |
|||
| L7820 | 高溶解性微型片段化合物库 | 1082 compounds | |
|
高溶解性微型片段化合物库由 xnu |
|||
| L7200 | 钙通道分子库 | 143 compounds | |
|
xnu |
|||
| L5400 | 抗心血管疾病化合物库 | 1428 compounds | |
|
xnu |
|||
| L2130 | 抗癌细胞代谢库 | 1280 compounds | |
|
xnu |
|||
| DC1040 | 特权片段注释化合物库-Transferases | 23001 compounds | |
| L9400 | PPI抑制剂库 | 260 compounds | |
|
xnu |
|||
| L7000 | 活性脂质化合物库 | 385 compounds | |
|
xnu |
|||
| L8700 | 铁死亡化合物库 | 800 compounds | |
|
xnu |
|||
| L1200 | 表观遗传库 | 960 compounds | |
|
xnu |
|||
| DC1030 | 特权片段注释化合物库-Epigenetics | 9196 compounds | |
| L1000 | 上市药物库 | 2863 compounds | |
|
xnu |
|||
| L2200 | 酪氨酸激酶分子库 | 746 compounds | |
|
xnu |
|||
| L7900 | 成骨分子库 | 320 compounds | |
|
xnu |
|||
| L8600 | 泛素化化合物库 | 214 compounds | |
|
xnu |
|||
| L6620 | 抗寄生虫天然产物库 | 233 compounds | |
|
xnu |
|||
| L2700 | 肾上腺素能受体化合物库 | 219 compounds | |
|
xnu |
|||
| L1110 | 微管靶向化合物库 | 80 compounds | |
|
xnu |
|||
| L9810 | 抗纤维化化合物库 | 1180 compounds | |
|
xnu |
|||
| L2120 | 抗癌临床化合物库 | 2359 compounds | |
|
xnu |
|||
| L6500 | 微生物天然产物库 | 193 compounds | |
|
xnu |
|||
| L4150 | 新颖已知活性精选库 | 990 compounds | |
|
xnu |
|||
| L2151 | 化疗药物库 | 51 compounds | |
|
xnu |
|||
| L7860 | Mini片段亲电杂环化合物库 | 369 compounds | |
|
高溶解度共价杂环片段库中的 xnu |
|||
| L6400 | 海洋天然产物库 | 94 compounds | |
|
xnu |
|||
| L6610 | 抗感染天然产物库 | 1070 compounds | |
|
xnu |
|||
| L6150 | 天然产物共价化合物库 | 596 compounds | |
| 提供产品的生物学信息和药物学信息，为筛选提供理论方向和研究基础； | |||
| L9410 | 共价抑制剂库 | 941 compounds | |
|
xnu |
|||
| DC1100 | 特权片段注释化合物库-GPCR Frizzled family | 3434 compounds | |
| L7810 | 高溶解性多官能团片段化合物库 | 1159 compounds | |
|
高溶解性多官能团片段库包含xnu |
|||
| DC1200 | 特权片段注释化合物库-Isomerases | 1206 compounds | |
| L8800 | 药物片段库 | 1158 compounds | |
|
xnu |
|||
| L9830 | 抗帕金森病化合物库 | 908 compounds | |
|
xnu |
|||
| L5500 | 毒性化合物库 | 277 compounds | |
|
xnu |
|||
| L6720 | 抗COVID-19中药单体库 | 1162 compounds | |
|
根据抗新冠肺炎疫情过程中应用于临床治疗的中药方剂，收集了xnu |
|||
| L1310 | 细胞骨架化合物库 | 590 compounds | |
|
xnu |
|||
| L5610 | Golden骨架库 | 10000 compounds | |
|
多样性好，从160万个小分子中挑选而出，xnu |
|||
| L1800 | 抗感染化合物库 | 2977 compounds | |
|
xnu |
|||
| L8000 | 干细胞分化化合物库 | 1213 compounds | |
|
xnu |
|||
| L6710 | 中药抗炎分子库 | 1040 compounds | |
|
xnu |
|||
| L2510 | 脂代谢化合物库 | 496 compounds | |
|
xnu |
|||
| L9820 | β-内酰胺类化合物库 | 105 compounds | |
|
xnu |
|||
| L4500 | 抗真菌库 | 253 compounds | |
|
xnu |
|||
| L3100 | 造血毒性小分子库 | 104 compounds | |
|
xnu |
|||
| L7850 | 高溶解性3D结构多样性片段化合物库 | 1081 compounds | |
|
高溶解性3D结构多样性片段库包含xnu |
|||
| L2300 | 离子通道库 | 946 compounds | |
|
xnu |
|||
| L4600 | 植物来源化合物库 | 2720 compounds | |
|
xnu |
|||
| DC1050 | 特权片段注释化合物库-Voltage-gated | 17952 compounds | |
| L2560 | 代谢化合物库 | 2350 compounds | |
|
xnu |
|||
| L6160 | Ro5类药天然产物库 | 2743 compounds | |
|
天然产物是先导化合物及候选药物的重要来源，其骨架结构复杂，官能团丰富，结构独特，多具有手性。这些自然形成的优势，为天然产物向药物的转化提供了更加多样的选择, 也是天然产物在药物开发与研究中发挥着重要作用的原因。
Target |
|||
| L9840 | 抗阿尔茨海默症化合物库 | 1040 compounds | |
|
xnu |
|||
| L6300 | 药食同源库 | 1088 compounds | |
|
xnu |
|||
| DC1110 | 特权片段注释化合物库-Proteases | 22863 compounds | |
| L6130 | 萜类天然产物库 | 349 compounds | |
|
xnu |
|||
| L6220 | 蒙药化合物库 | 960 compounds | |
|
xnu |
|||
| DC1010 | 特权片段注释化合物库-GPCR Family A | 24763 compounds | |
| L8200 | 抗衰老化合物库 | 3324 compounds | |
|
xnu |
|||
| L2530 | 小鼠代谢化合物库 | 224 compounds | |
|
xnu |
|||
| L7840 | 高溶解性卤化片段化合物库 | 796 compounds | |
|
高溶解性卤化片段库包含xnu |
|||
| L2520 | 糖代谢化合物库 | 708 compounds | |
|
xnu |
|||
| L9100 | 磷酸酶抑制剂化合物库 | 80 compounds | |
|
xnu |
|||
| L3510 | 甲基化化合物库 | 131 compounds | |
|
xnu |
|||
| L9600 | 多肽分子库 | 533 compounds | |
|
xnu |
|||
| L2800 | 5-羟色胺分子库 | 275 compounds | |
|
xnu |
|||
| L6030 | 天然产物衍生物虚筛化合物库 | 135000 compounds | |
| 13.5万种天然产物衍生物，并且在持续增加中； | |||
| DC1000 | 特权片段注释化合物库 | 190000 compounds | |
|
The database contains 190k s |
|||
| L4100 | TGF-β/Smad靶点化合物库 | 180 compounds | |
|
xnu |
|||
| L4400 | 抗生素库 | 708 compounds | |
|
xnu |
|||
| L6100 | 天然多酚类化合物库 | 640 compounds | |
|
xnu |
|||
| L7830 | 高溶解性片段药效团化合物库 | 985 compounds | |
|
高溶解性片段药效团库包含xnu |
|||
| L2600 | 神经信号分子库 | 2011 compounds | |
|
xnu |
|||
| DP1300 | h-TERT靶向化合物库 | ||
| L2540 | 肠道微生物代谢化合物库 | 352 compounds | |
|
xnu |
|||
| L6810 | 中药单体化合物库 | 2688 compounds | |
|
xnu |
|||
| DC1130 | 特权片段注释化合物库-Phosphodiesterases | 13154 compounds | |
| DC1060 | 特权片段注释化合物库-Kinases | 18350 compounds | |
| L1720 | 核苷类化合物库 | 337 compounds | |
|
xnu |
|||
| L2900 | 氧化还原化合物库 | 1279 compounds | |
|
xnu |
|||
| L5600 | Mini骨架库 | 5033 compounds | |
|
多样性好，从一百多万个小分子中挑选而出，xnu |
|||
| L9200 | 药物功能重定位化合物库 | 4240 compounds | |
|
xnu |
|||
| DC1220 | 特权片段注释化合物库-Aminoacyltransferases | 3008 compounds | |
| L6110 | 生物碱类天然产物库 | 468 compounds | |
|
xnu |
|||
| DC1210 | 特权片段注释化合物库-Phosphatases | 15354 compounds | |
| L8300 | 染色质修饰分子库 | 256 compounds | |
|
xnu |
|||
| L9000 | 细胞凋亡化合物库 | 1796 compounds | |
|
xnu |
|||
| DC1160 | 特权片段注释化合物库-Toll-like and Il-1 receptors | 3536 compounds | |
| L6600 | 胃肠炎天然产物库 | 223 compounds | |
|
xnu |
|||
| DP9100 | CB1-2化合物库 | ||
| L9300 | 大环化合物库 | 155 compounds | |
|
xnu |
|||
| DC1090 | 特权片段注释化合物库-Ligases | 11828 compounds | |
| L7700 | 神经再生化合物库 | 529 compounds | |
|
xnu |
|||
| L5510 | 肝脏毒性化合物库 | 1040 compounds | |
|
xnu |
|||
| L2100 | 抗癌化合物库 | 6854 compounds | |
|
xnu |
|||
| L6120 | 黄酮类天然产物库 | 477 compounds | |
|
xnu |
|||
| L2570 | 人代谢物化合物库 | 4532 compounds | |
|
xnu |
|||
| DQ3000 | Factor XIa化合物库 | 6500 compounds | |
| L6210 | 藏药化合物库 | 754 compounds | |
|
xnu |
|||
| L6200 | 瑶药化合物库 | 225 compounds | |
|
xnu |
|||
| DC1080 | 特权片段注释化合物库-GPCR Taste family | 2675 compounds | |
| L2500 | 人内源代谢化合物库 | 1400 compounds | |
|
xnu |
|||
| DC1120 | 特权片段注释化合物库-Thrombopoietin receptors | 4908 compounds | |
| L5800 | 药物代谢杂质库 | 200 compounds | |
|
xnu |
|||
| L3600 | 细胞因子抑制剂库 | 613 compounds | |
|
xnu |
|||
| L1580 | GPCR库Plus | 338 compounds | |
|
xnu |
|||
| L4010 | 已知活性化合物库 | 20980 compounds | |
|
xnu |
|||
| L1600 | 激酶抑制剂库 | 2230 compounds | |
|
xnu |
|||
| L1610 | FDA 上市激酶抑制剂库 | 280 compounds | |
|
Target |
|||
| L6900 | 稀有天然产物库 | 284 compounds | |
|
xnu |
|||
| L4020 | NO PAINS 化合物库 | 9555 compounds | |
|
Target |
|||
| L4800 | 血管生成库 | 1370 compounds | |
|
xnu |
|||
| DO2200 | 共价抑制剂库CD | 12000 compounds | |
| 数量多：超过12000种共价结合化合物，并且数量在持续增加； | |||
| L1700 | 抗病毒库 | 800 compounds | |
|
xnu |
|||
| L1510 | 核受体化合物库 | 420 compounds | |
|
xnu |
|||
| DC1230 | 特权片段注释化合物库-Beta amyloid A4 protein | 4617 compounds | |
| DF4500 | 多样性核心库Part1 | 50000 compounds | |
|
绝大部分分子量<500，主要集中于250- |
|||
| L7800 | 高溶解性片段库 | 2731 compounds | |
|
xnu |
|||
| L6140 | 糖类及苷类化合物库 | 364 compounds | |
|
xnu |
|||
| L3400 | 临床期小分子药物库 | 3142 compounds | |
|
xnu |
|||
| L8110 | 细胞重编程化合物库 | 1840 compounds | |
|
xnu |
|||
| L2140 | 癌细胞分化化合物库 | 413 compounds | |
|
xnu |
|||
| L5200 | 抗代谢疾病化合物库 | 1558 compounds | |
|
xnu |
|||
| DP5580 | Ephrin-4B靶向化合物库 | ||
| L2152 | 靶向治疗药物库 | 121 compounds | |
|
xnu |
|||
| L1400 | MAPK 抑制剂库 | 367 compounds | |
|
xnu |
|||
| L3800 | NF-κB 通路分子库 | 560 compounds | |
|
xnu |
|||
| L6800 | 中国药典收录天然产物库 | 2070 compounds | |
|
xnu |
|||
| L1300 | PI3K/Akt/mTOR 化合物库 | 425 compounds | |
|
xnu |
|||
| DC1070 | 特权片段注释化合物库-GPCR Family C | 5071 compounds | |
| L2190 | 抗肺癌化合物库 | 1735 compounds | |
|
xnu |
|||
| L1900 | 抗糖尿病库 | 690 compounds | |
|
xnu |
|||
| L2910 | 抗氧化化合物库 | 1040 compounds | |
|
氧化应激（Oxidative Stress，OS）是指体内氧化与抗氧化作用失衡的一种状态。氧化应激导致活性氧（ROS）大量积累，氧化程度超出抗氧化物的清除能力，从而引起氧化损伤，氧化应激损伤是许多疾病发生的基础，不同程度的氧化应激造成的细胞效应与心脑血管疾病、神经退行性病变、炎症和肿瘤密切相关。抗氧化剂是一类能够对抗氧化应激，降低氧化损伤的一类化合物。
Target |
|||
| L7870 | 可溶性羧酸片段化合物库 | 1807 compounds | |
|
可溶性羧酸片段库包含xnu |
|||
| L7100 | 抗肥胖化合物库 | 1359 compounds | |
|
xnu |
|||
| L7400 | 钠通道分子库 | 128 compounds | |
|
xnu |
|||
| L6000 | 高通量筛选天然产物库 | 4320 compounds | |
|
xnu |
|||
| L4700 | 免疫/炎症分子化合物库 | 3483 compounds | |
|
xnu |
|||
| L3980 | DNA损伤/修复库Plus | 667 compounds | |
|
xnu |
|||
| L5100 | 含氟化合物库 | 583 compounds | |
|
xnu |
|||
| L2521 | 糖酵解化合物库 | 560 compounds | |
|
xnu |
|||
| L8400 | 血液病分子库 | 524 compounds | |
|
xnu |
|||
| L4300 | Wnt/Hedgehog/Notch 通路化合物库 | 240 compounds | |
|
xnu |
|||
| L2620 | 神经退行性疾病化合物库 | 1622 compounds | |
|
xnu |
|||
| L2180 | 抗肿瘤库Plus | 1468 compounds | |
|
xnu |
|||
| L4510 | 抗寄生虫库 | 336 compounds | |
|
xnu |
|||
| L8500 | HIF-1化合物库 | 1352 compounds | |
|
xnu |
|||
| L4200 | FDA 上市药物库 | 1729 compounds | |
|
xnu |
|||
| Cat. No. | Product Name | Form | Specificity Of Inhibition |
|---|---|---|---|
| C0005 |
Cell Counting Kit-8 (CCK-8)
Cell Counting Kit-8 (CCK-8) |
||
| C0003 |
Phosphatase Inhibitor Cocktail II (100× DMSO)
磷酸酶抑制剂 Cocktail II |
||
| C0004 |
Phosphatase Inhibitor Cocktail III (2 Tubes, 100x)
磷酸酶抑制剂 Cocktail III |
||
| C0008 |
SYBR Green qPCR Master Mix (Low ROX)
SYBR Green qPCR Master Mix (Low ROX) |
||
| C0007 |
SYBR Green qPCR Master Mix (High ROX)
SYBR Green qPCR Master Mix (High ROX) |
| Cat. No. | Product Name | ||
|---|---|---|---|
| EC2000 | 全自动封板仪 | ||
| Target |
|||
| Cat. No. | Product Name | ||
|---|---|---|---|
| EC3000 | TargetMol® 24 道磁力架 | ||
| 强力钕磁铁部件，吸附效率高，可兼容所有磁珠。助力核酸分离、蛋白纯化、细胞分选！可同时分离 2 |
|||
| EC6000 | EP管低温冰浴盒 | ||
| E |
|||
| EC4000 | TargetMol® 高通量开盖器 | ||
| Target |
|||
| Cat. No. | Product Name | Target | Signaling Pathways |
|---|---|---|---|
| T33194 | m-Anisidine, 4-((p-(methylsulfonyl)benzyl)oxy)- | ||
| m-Anisidine, 4-((p-(methylsulfonyl)benzyl)oxy)- is a bioactive chemical. | |||
沪公网安备 31010602006700号
